DEXCOM INC. DL-,001/ US2521311074 /
2024-06-03 2:36:40 PM | Chg. +0.62 | Volume | Bid2:36:40 PM | Ask2:36:40 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
109.36EUR | +0.57% | - Turnover: - |
109.36Bid Size: - | 109.74Ask Size: - | 43.55 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.